• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Protein Microarray Companies

    ID: MRFR/LS/3868-HCR
    90 Pages
    Rahul Gotadki
    October 2025

    Protein microarrays are powerful tools in proteomics, allowing researchers to study interactions between proteins, identify protein biomarkers, and analyze protein expression patterns.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Protein Microarray Market

    Protein Microarray Key CompaniesLatest Protein Microarray Companies Update

    October 2023: A new platform for the analysis of autoantibodies linked to disease diagnosis and therapeutic intervention, i-Ome Discovery, has been launched by Sengenics Corporation LLC, a pioneer in immune response profiling that supports scientific discovery and diagnostic development. Researchers in the fields of academia and clinical biopharmaceutics are using the i-Ome Discovery platform to help them better comprehend the complex web of linkages and interactions that exists among proteins, the immune system, and illness. In order to identify autoantibodies with unprecedented sensitivity, specificity, and repeatability, i-Ome Discovery makes use of Sengenics' proprietary KREX® technology. This technique provides completely functioning, full-length autoantigen proteins that have been correctly folded.


    September 2023: Tuning Fork Bio Inc. was founded in USA by Yamaha Motor Co., Ltd. The company's goal is to use antibody profiling to better understand people's health situations by analyzing blood antibodies. The United States and Japan are the primary focus areas for this new business. With the help of Tuning Fork Bio's cutting-edge antibody analysis technology, a patient's present health state may be studied through antibody profiling. This process involves selecting antibodies, which are proteins, that are associated with various diseases and comparing them with the patient's own antibodies. Medical institutions' health screenings, patients' medication selection, and pharmaceutical corporations' research into new pharmaceuticals will all profit from this data. An individual's antibody repertoire may be searched exhaustively by comparing the microarray's protein binding states with those of the antibodies in the blood.


    List of Protein Microarray Key companies in the market

    • Thermo Fisher Scientific (U.S)

    • Agilent Technologies (U.S.)

    • Hoffmann-La Roche AG (Genentech) (Switzerland)

    • Illumina Inc. (U.S.)

    • Abbott Laboratories (U.S.)

    • PerkinElmer Inc. (U.S.)

    • Fluidigm Corporation (U.S.)

    • GE Healthcare (U.S.)

    • Bio-Rad Laboratories Inc. (U.S.)

    • Cepheid Inc. (U.S.)

    • SEQUENOM, Inc. (U.S.)

    • Sigma Aldrich Corporation (U.S.)

    • Affymetrix, Inc. (U.S.)

    • EMD Millipore (U.S.)

    • Medtronic Inc. (U.S.)

    • Angioscore Ltd. (U.S.)